How will Cephalon shift patients to Nuvigil?
The pharmaceutical industry is no stranger to dirty tricks and shady dealings in a bid to keep its customers coming back time and again. Although they would prefer to call it “just doing business”.
Indeed shifting patients from a soon-to-go-off-patent blockbuster, to its tweaked successor is old hat in the pharma biz.
Ever since drugmakers figured out [...]